AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionBlue Edge Capital, LLC
Latest Disclosed Ownership6,764 shares
Latest Disclosed Value $ 1,471,002
Blue Edge Capital, LLC reports 6.12% increase in ownership of 4AB / AbbVie Inc.

On June 2, 2026 - Blue Edge Capital, LLC filed a 13F-HR form disclosing ownership of 6,764 shares of AbbVie Inc. (BG:4AB) valued at $1,471,002 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 6,374 shares of AbbVie Inc.. This represents a change in shares of 6.12% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-02 2026-03-31 13F Abbvie COM 00287Y109 6,764 390 6.12 1,471 1.03 0.1954
2026-02-12 2025-12-31 13F Abbvie COM 00287Y109 6,374 -100 -1.54 1,456 -2.80 0.1948
2025-11-12 2025-09-30 13F Abbvie COM 00287Y109 6,474 0 0.00 1,499 24.73 0.2129
2025-08-15 2025-06-30 13F Abbvie COM 00287Y109 6,474 -237 -3.53 1,202 -14.58 0.1787
2025-05-13 2025-03-31 13F Abbvie COM 00287Y109 6,711 2 0.03 1,406 17.95 0.2258
2025-02-13 2024-12-31 13F Abbvie COM 00287Y109 6,709 2 0.03 1,192 -9.97 0.1875
2024-11-14 2024-09-30 13F Abbvie COM 00287Y109 6,707 1,483 28.39 1,324 47.93 0.2063
2024-08-07 2024-06-30 13F Abbvie COM 00287Y109 5,224 0 0.00 896 -5.89 0.1483
2024-05-15 2024-03-31 13F Abbvie COM 00287Y109 5,224 0 0.00 951 17.55 0.1591
2024-02-15 2023-12-31 13F Abbvie COM 00287Y109 5,224 0 0.00 809 3.98 0.1526
2023-11-14 2023-09-30 13F Abbvie COM 00287Y109 5,224 0 0.00 779 10.67 0.1632
2023-08-21 2023-06-30 13F Abbvie COM 00287Y109 5,224 0 0.00 704 -15.50 0.1418
2023-05-16 2023-03-31 13F Abbvie COM 00287Y109 5,224 0 0.00 832 -1.42 0.1800
2023-02-13 2022-12-31 13F Abbvie COM 00287Y109 5,224 1 0.02 844 20.40 0.1924
2022-11-15 2022-09-30 13F Abbvie COM 00287Y109 5,223 -1 -0.02 701 -12.37 0.1736
2022-08-10 2022-06-30 13F Abbvie COM 00287Y109 5,224 -184 -3.40 800 -8.68 0.1859
2022-05-16 2022-03-31 13F Abbvie COM 00287Y109 5,408 184 3.52 877 23.90 0.1756
2022-02-14 2021-12-31 13F Abbvie COM 00287Y109 5,224 0 0.00 707 25.58 0.1365
2021-11-15 2021-09-30 13F Abbvie COM 00287Y109 5,224 1 0.02 563 -4.25 0.1176
2021-08-13 2021-06-30 13F Abbvie COM 00287Y109 5,223 -1 -0.02 588 4.07 0.1221
2021-05-12 2021-03-31 13F Abbvie COM 00287Y109 5,224 0 0.00 565 1.07 0.1257
2021-02-09 2020-12-31 13F Abbvie COM 00287Y109 5,224 0 0.00 560 22.32 0.1352
2020-11-04 2020-09-30 13F Abbvie COM 00287Y109 5,224 -175 -3.24 458 -13.77 0.1246
2020-08-10 2020-06-30 13F Abbvie COM 00287Y109 5,399 175 3.35 530 33.50 0.1589
2020-05-12 2020-03-31 13F Abbvie COM 00287Y109 5,224 2,400 84.99 398 71.12 0.1440
2020-02-12 2019-12-31 13F Abbvie COM 00287Y109 2,824 0 0.00 232 8.92 0.0734
2019-11-13 2019-09-30 13F Abbvie COM 00287Y109 2,824 0 0.00 214 3.90 0.0732
2019-08-13 2019-06-30 13F Abbvie COM 00287Y109 2,824 0 0.00 205 -9.69 0.0719
2019-05-14 2019-03-31 13F Abbvie COM 00287Y109 2,824 3 0.11 228 -12.69 0.0864
2019-02-14 2018-12-31 13F Abbvie COM 00287Y109 2,821 3 0.11 260 -2.26 0.1120
2018-11-15 2018-09-30 13F Abbvie COM 00287Y109 2,818 2 0.07 267 2.31 0.0990
2018-08-14 2018-06-30 13F Abbvie COM 00287Y109 2,816 2 0.07 261 -2.26 0.1044
2018-05-14 2018-03-31 13F Abbvie COM 00287Y109 2,814 -299 -9.60 266 -11.63 0.1073
2018-02-15 2017-12-31 13F Abbvie COM 00287Y109 3,113 301 10.70 301 20.88 0.1202
2017-11-15 2017-09-30 13F Abbvie COM 00287Y109 2,812 2 0.07 250 22.66 0.1140
2017-08-14 2017-06-30 13F Abbvie COM 00287Y109 2,810 2,810 204 0.0961
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.